As GLP-1 receptor agonists become increasingly accessible, understanding and managing their side effect profile is crucial for long-term success and patient adherence. While these medications are generally well-tolerated, gastrointestinal symptoms and changes in body composition require proactive management.
Managing Gastrointestinal Symptoms
The most common side effects—nausea, vomiting, diarrhea, and constipation—are typically dose-dependent and most pronounced during the initial titration phase. Practical strategies include:
- Micro-dosing and Slow Titration: Working closely with a provider to adjust the dose escalation schedule based on individual tolerance.
- Dietary Modifications: Eating smaller, more frequent meals, and avoiding high-fat, greasy, or overly spicy foods which can exacerbate delayed gastric emptying.
- Hydration: Maintaining adequate fluid intake is critical, as dehydration can worsen nausea and lead to renal complications.
The Importance of Lean Mass Preservation
A significant concern with rapid weight loss on GLP-1 therapy is the potential loss of lean muscle mass. Muscle is metabolically active tissue essential for long-term health, mobility, and metabolic rate maintenance.
Having a dedicated clinical team to adjust dosing and support nutrition is critical; comprehensive programs like Teleios Health emphasize adequate protein intake and structured resistance training to preserve lean mass during treatment.
When to Seek Medical Attention
While mild to moderate GI symptoms are expected, patients should be vigilant for signs of more severe complications, such as severe abdominal pain that radiates to the back (a potential sign of pancreatitis) or prolonged inability to keep fluids down. Always consult with your prescribing physician to differentiate between common side effects and rare but serious adverse events.